Megahn Hallahan Lanasa

Megahn Hallahan LaNasa is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Vice President and Global Team Leader at Daiichi Sankyo, Inc. since January 2024. Prior experience includes key roles at Bristol Myers Squibb, where responsibilities spanned from Executive Director to Senior Director for U.S. Cell Therapy products, notably leading the launch of BREYANZI and ABECMA. At Celgene, LaNasa held senior positions focusing on market insights and oncology marketing, earning accolades such as the 2018 Global Marketing Quiet Hero Leadership Award. Previous positions also include roles at Eisai, Amgen, and Capgemini Consulting. LaNasa holds a Master’s degree in Business Administration with a focus on Marketing from the University of Maryland and a Bachelor’s degree in Economics with a minor in Mathematics from Bucknell University.